Cargando…

New Approach for Interpreting Changes in Circulating Tumour Cells (CTC) for Evaluation of Treatment Effect in Metastatic Breast Cancer

Aim: Attempts have been made to use CTC values for interpretation of treatment response and to guide change of chemotherapy by using a static cut-off of 5 CTC to stratify patients in favourable or unfavourable responders. We propose a new approach to interpret treatment effect using significant chan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horn, Peer, Jakobsen, Erik Hugger, Madsen, Jonna Skov, Brandslund, Ivan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311024/ https://www.ncbi.nlm.nih.gov/pubmed/25500078 http://dx.doi.org/10.1016/j.tranon.2014.09.010

Ejemplares similares

Quantification of Cell-Free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene Amplification
por: Sørensen, Patricia Diana, et al.
Publicado: (2015)

Prognostic impact of serum levels of EGFR and EGFR ligands in early-stage breast cancer
por: Kjær, Ina Mathilde, et al.
Publicado: (2020)

Dysregulated EGFR pathway in serum in early-stage breast cancer patients: A case control study
por: Kjær, Ina Mathilde, et al.
Publicado: (2020)

Predicting brain metastases of breast cancer based on serum S100B and serum HER2
por: BECHMANN, TROELS, et al.
Publicado: (2013)

Phase II trial of delta-tocotrienol in neoadjuvant breast cancer with evaluation of treatment response using ctDNA
por: Kjær, Ina Mathilde, et al.
Publicado: (2023)

Circulating Tumour Cells (CTC), Head and Neck Cancer and Radiotherapy; Future Perspectives
por: Perumal, Vanathi, et al.
Publicado: (2019)

CTC-5: A novel digital pathology approach to characterise circulating tumour cell biodiversity
por: Ffrench, B., et al.
Publicado: (2023)

DanioCTC: Analysis of Circulating Tumor Cells from Metastatic Breast Cancer Patients in Zebrafish Xenografts
por: Reinhardt, Florian, et al.
Publicado: (2023)

Single nucleotide variant profiles of viable single circulating tumour cells reveal CTC behaviours in breast cancer
por: Wang, Yipeng, et al.
Publicado: (2018)

Exploration of Circulating Tumour Cell (CTC) Biology: A Paradigm Shift in Liquid Biopsy
por: Chauhan, Anshika, et al.
Publicado: (2020)

Recent Update Roles of Magnetic Nanoparticles in Circulating Tumor Cell (CTC)/Non-CTC Separation
por: Pipatwatcharadate, Chawapon, et al.
Publicado: (2023)

Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
por: Spindler, Karen Lise Garm, et al.
Publicado: (2015)

HER2-targeted therapy influences CTC status in metastatic breast cancer
por: Deutsch, Thomas M., et al.
Publicado: (2020)

RNA-Based CTC Analysis Provides Prognostic Information in Metastatic Breast Cancer
por: Strati, Areti, et al.
Publicado: (2021)

Immediate Sample Fixation Increases Circulating Tumour Cell (CTC) Capture and Preserves Phenotype in Head and Neck Squamous Cell Carcinoma: Towards a Standardised Approach to Microfluidic CTC Biomarker Discovery
por: Payne, Karl, et al.
Publicado: (2021)

Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization
por: Werner, Shannon L., et al.
Publicado: (2015)

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2019)

In vitro detection of circulating tumor cells compared by the CytoTrack and CellSearch methods
por: Hillig, Thore, et al.
Publicado: (2015)

Rapid SARS-CoV-2 Detection Using Electrochemical Immunosensor
por: Mojsoska, Biljana, et al.
Publicado: (2021)

Cut-Off Analysis of CTC Change under Systemic Therapy for Defining Early Therapy Response in Metastatic Breast Cancer
por: Deutsch, Thomas M., et al.
Publicado: (2020)

Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast Cancer
por: Mego, M, et al.
Publicado: (2016)

The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma
por: Guan, Yibing, et al.
Publicado: (2021)

Technical Challenges for CTC Implementation in Breast Cancer
por: Ramos-Medina, Rocío, et al.
Publicado: (2021)

Decreased concentrations of intracellular signaling proteins in colon cancer patients with BRAF mutations
por: Olsen, Dorte Aa., et al.
Publicado: (2020)

Complementary Sequential Circulating Tumor Cell (CTC) and Cell-Free Tumor DNA (ctDNA) Profiling Reveals Metastatic Heterogeneity and Genomic Changes in Lung Cancer and Breast Cancer
por: Kong, Say Li, et al.
Publicado: (2021)

miRNA in situ hybridization in circulating tumor cells - MishCTC
por: Ortega, Francisco G., et al.
Publicado: (2015)

Analysis of a Real-World Cohort of Metastatic Breast Cancer Patients Shows Circulating Tumor Cell Clusters (CTC-clusters) as Predictors of Patient Outcomes
por: Costa, Clotilde, et al.
Publicado: (2020)

Aneuploid CTC and CEC
por: Lin, Peter Ping
Publicado: (2018)

Landscape of circulating tumour DNA in metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2020)

Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease
por: Hanssen, Annkathrin, et al.
Publicado: (2018)

How to Agree on a CTC: Evaluating the Consensus in Circulating Tumor Cell Scoring
por: Zeune, Leonie L., et al.
Publicado: (2018)

Role of Circulating Tumor Cell (CTC) Monitoring in Evaluating Prognosis of Triple-Negative Breast Cancer Patients in China
por: Zhang, Yanwu, et al.
Publicado: (2017)

Evaluation of the diagnostic value of circulating tumor cells with CytoSorter(®) CTC capture system in patients with breast cancer
por: Jin, Lidan, et al.
Publicado: (2020)

57. CIRCULATING TUMOR CELLS (CTC) IN CEREBROSPINAL FLUID (CSF) AS A PREDICTOR OF SURVIVAL IN CNS METASTASES
por: Diaz, Maria, et al.
Publicado: (2020)

Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase I gene
por: Kümler, Iben, et al.
Publicado: (2019)

The Lack of Evidence for an Association between Cancer Biomarker Conversion Patterns and CTC-Status in Patients with Metastatic Breast Cancer
por: Stefanovic, Stefan, et al.
Publicado: (2020)

Serum vitamin K(1) associated to microangiopathy and/or macroangiopathy in individuals with and without diabetes
por: Bøgh Andersen, Ida, et al.
Publicado: (2020)

Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
por: Polasik, Arkadius, et al.
Publicado: (2017)

The isolation and characterization of CTC subsets related to breast cancer dormancy
por: Vishnoi, Monika, et al.
Publicado: (2015)

Magnetic Particles for CTC Enrichment
por: Liu, Peng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tmj4a5ie0rrrjcfvtpghl95ie5